Top

Published in:

01-03-2013 | Erratum

Erratum to: Should hyperthermia be included in the benefit catalogue for oncologic indications? Commercial interests are presumed behind the editorial of R. Sauer et al.

Authors: Prof. Dr. R. Sauer, C. Wild

Published in: Strahlentherapie und Onkologie | Issue 3/2013

Excerpt

The authors regret a typing error on page 84 in the section Authors’ reply by R. Sauer, H. Crezee et al. The correct subheading should be (indicated in italics): The letter of the Ludwig Boltzmann Institute is unnecessarily polarizing to the discussion on whether or not hyperthermia is evidence based. …

Title: Erratum to: Should hyperthermia be included in the benefit catalogue for oncologic indications? Commercial interests are presumed behind the editorial of R. Sauer et al.
Authors: Prof. Dr. R. Sauer
C. Wild
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 3/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0317-2

At a glance: The STEP trials

Springer Medicine

Erratum to: Should hyperthermia be included in the benefit catalogue for oncologic indications? Commercial interests are presumed behind the editorial of R. Sauer et al.

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2013

In vitro hypoxic cytotoxicity and hypoxic radiosensitization

Xerostomia after radiotherapy

Zum Gedenken an Roch Kowalski

Prof. Dr. Hans-Joachim Thiel zum 65. Geburtstag und zur Würdigung seiner berufspolitischen Tätigkeit

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy

Professor Manfred Strietzel zum 85. Geburtstag